Guerin Mark Patrick 4
4 · Onconova Therapeutics, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Guerin Mark Patrick
Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2024-03-14$0.90/sh−2,591$2,332→ 35,976 total - Exercise/Conversion
Restricted Stock Units
2024-03-13−8,666→ 17,334 total→ Common Stock (8,666 underlying) - Exercise/Conversion
Common Stock
2024-03-13+8,666→ 38,567 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On March 13, 2023 the reporting person was granted 26,000 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.